Expressions of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations

Journal of Clinical Neuroscience

Volumn 17, Issue 2, 2010, Pages 232-236

  Bicer, Atilla ^a   Guclu, Bulent ^a   Ozkan, Abdulkadir ^a   Kurtkaya, Ozlem ^a   Koc, Demet Yalcinkaya ^a   Necmettin Pamir, M ^a   Kilic, Turker ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Cerebral arteriovenous malformation; Cerebral cavernous malformation; Fibronectin; Laminin; Matrix metalloproteinase; Tenascin

Indexed keywords

FIBRONECTIN; GELATINASE A; GELATINASE B; LAMININ; MATRIX METALLOPROTEINASE; PROTEIN ANTIBODY; SCLEROPROTEIN; TENASCIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL WALL; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN DAMAGE; CEREBROVASCULAR MALFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYONAL TISSUE; ENDOTHELIUM; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SUBENDOTHELIUM; TISSUE SECTION;

BIOLOGICAL MARKERS; CEREBRAL ARTERIES; CEREBRAL VEINS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; TENASCIN;

EID: 73449100421     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.06.008     Document Type: Article

References (37)

1. Challa V.R., Moody D.M., and Brown W.R. Vascular malformations in the central nervous system. J Neuropathol Exp Neurol 54 (1995) 609-621
2. Selman W.R., Tarr R.W., and Ratcheson R.A. In: Batjler H.H., Caplan L.R., Friberg L., Greenlee Jr. R.G., Kopitnik Jr. T.A., and Young W.L. (Eds). Intracranial arteriovenous malformations: patient evaluation and considerations for treatment (1997), Lippincott-Raven, Philedelphia 679-690
3. Steiger H.J., Markwalder T.M., and Reulen H.J. Clinicopathological relations of cerebral cavernous angiomas: observations in eleven cases. Neurosurgery 21 (1987) 879-884
4. Konya D., Yildirim O., Kurtkaya O., et al. Testing the angiogenic potential of cerebrovascular malformations by use of a rat cornea model: usefulness and novel assessment of changes over time. Neurosurgery 56 (2005) 1339-1345
5. Harrigan M.R. Angiogenic factors in the central nervous system. Neurosurgery 53 (2003) 639-660
6. Zadeh G., and Guha A. Angiogenesis in nervous system disorders. Neurosurgery 53 (2003) 1362-1374
7. Hashimoto T., Emala C.W., Joshi S., et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47 (2000) 910-919
8. Kilic T., Pamir M.N., Küllü S., et al. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46 (2000) 1179-1192
9. Uranishi R., Baev N.I., Ng P.Y., et al. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48 (2001) 359-367
10. Kittelberger R., Davis P.F., and Stehbens W.E. Distribution of Type IV collagen, laminin, nidogen and fibronectin in the hemodynamically stressed vascular wall. Histol Histopathol 5 (1990) 161-167
11. Risau W., and Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125 (1988) 441-450
12. Zagzag D., Friedlander D.R., Dosik J., et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 56 (1996) 182-189
13. Dejana E., Lampugnani M.G., Giorgi M., et al. Fibrinogen induces endothelial cell adhesion and spreading via the release of endogenous matrix proteins and the recruitment of more than one integrin receptor. Blood 75 (1990) 1509-1517
14. Barstch U. The extracellular matrix molecule tenascin-C: expression in vivo and functional characterization in vitro. Prog Neurobiol 49 (1996) 145-168
15. Kilic T., Bayri Y., Ozduman K., et al. Tenenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 51 (2002) 183-192
16. Garbisa S., and Negro A. Macromolecular organization and functional architecture of basement membranes. Appl Path 2 (1984) 217-222
17. Bergers G., Brekken R., McMahon G., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 (2000) 737-744
18. Fang J., Shing Y., Wiederschain D., et al. Matrix metalloproteinase-2 is required for the switch to the angiogenesis phenotype in a tumor model. Proc Natl Acad Sci 97 (2000) 3884-3889
19. Nguyen M., Arkell J., and Jackson C.J. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33 (2001) 960-970
20. Nordqvist C.S., Smurawa H., and Mathiesen T. Expression of matrix metalloproteinase 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg 95 (2001) 839-844
21. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9 (2005) 267-285
22. Rothbart D., Awad I.A., Lee J., et al. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38 (1996) 915-924
23. Gault J., Sarin H., Awadallah N., et al. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 55 (2004) 1-17
24. Klagsbrun M., and D'Amore P.A. Regulators of angiogenesis. Annu Rev Physiol 53 (1991) 217-239
25. Hashimoto T., Lawton M.T., Wen G., et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54 (2004) 410-423
26. Little J.R., Awad I.A., Jones S.C., et al. Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg 73 (1990) 555-559
27. Seker A., Yildirim O., Kurtkaya O., et al. Expression of integrins in cerebral arteriovenous and cavernous malformations. Neurosurgery 58 (2006) 159-168
28. Liakka A., Apaja-Sarkkinen M., Karttunen T., et al. Distribution of laminin and types IV and III collagen in fetal, infant and adult human spleens. Cell Tissue Res 263 (1991) 245-252
29. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
30. Fujimura M., Watanabe M., Shimizu H., et al. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2. Acta Neurochir (Wien) 149 (2007) 179-183
31. Hashimoto T., Wen G., Lawton M.T., et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34 (2003) 925-931
32. Gasche Y., Copin J.C., Sugawara T., et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21 (2001) 1393-1400
33. Montaner J., Alvarez-Sabin J., Molina C.A., et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32 (2001) 2762-2767
34. Kader A., and Young W.L. The effects of intracranial arteriovenous malformations on cerebral hemodynamics. Neurosurg Clin N Am 7 (1996) 767-781
35. Porter P.J., Willinsky R.A., Harper W., et al. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 87 (1997) 190-197
36. Coffin J.D., and Poole T.J. Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos. Development 102 (1988) 735-748
37. Mullan S., Mojtahedi S., Johnson D.L., et al. Embryological basis of some aspects of cerebral vascular fistulas and malformations. J Neurosurg 85 (1996) 1-8